CCR4-NOT is a conserved multiprotein complex which regulates eukaryotic gene expression principally via shortening of poly(A) tails of messenger RNA or deadenylation. Here, we reconstitute a complete, recombinant human CCR4-NOT complex. Our reconstitution strategy permits strict compositional control to test mechanistic hypotheses with purified component variants. CCR4-NOT is more active and selective for poly(A) than the isolated exonucleases, CCR4a and CAF1, which have distinct deadenylation profiles in vitro. The exonucleases require at least two out of three conserved non-enzymatic modules (CAF40, NOT10:NOT11 or NOT) for full activity in CCR4-NOT. CAF40 and the NOT10:NOT11 module both bind RNA directly and stimulate deadenylation in a partially redundant manner. Linear motifs from different RNA-binding factors that recruit CCR4-NOT to specific mRNAs via protein-protein interactions with CAF40 can inhibit bulk deadenylation. We reveal an additional layer of regulatory complexity to the human deadenylation machinery, which may prime it either for general or target-specific degradation.
T he poly(A) tails at 3′ ends of eukaryotic mRNAs are crucial for their cytoplasmic stability and to enhance the initiation of translation. Newly synthesized metazoan mRNAs possess long poly(A) tails 1 , and following export to the cytoplasm the tails are reported to be~60-80 nucleotides on average at steady state 2 . Poly(A) tails are also important for translational efficiency at the embryonic stage 2 and the length of the poly(A) tail was reported to be correlated with translational efficiency 3 . The multisubunit CCR4-NOT complex is principally responsible for efficient processive shortening of poly(A) tails, or deadenylation, in addition to other functions [4] [5] [6] [7] . In addition to its role in bulk mRNA decay, CCR4-NOT can also catalyze the deadenylation or promote translational repression of specific mRNA targets to which it is recruited by RNA binding proteins, such as Nanos, Roquin and Puf/Pumilio proteins [8] [9] [10] [11] [12] [13] . In animals, CCR4-NOT functions in cytoplasmic microRNA-mediated gene silencing via a direct interaction with the GW182/TNRC6 proteins 8, 14, 15 , as well as in the nuclear miRNA-mediated gene silencing, which is critical for stem cell differentiation 16 .
The CCR4-NOT complex consists of two exonucleases, CCR4 and CAF1, as well as the non-enzymatic proteins NOT1, NOT2, NOT3, and CAF40 which are conserved in all eukaryotes ( Fig. 1a ). NOT1 is an essential subunit of CCR4-NOT and functions as a scaffold on which other subunits and modules dock [17] [18] [19] . The highly conserved CAF40 and NOT2/3 subunits act as protein-protein interaction platforms for sequence-specific RNA-binding proteins 10, 11, 13, 20 . The exonucleases CCR4a (NOT6) and CCR4b (NOT6L) are vertebrate orthologs of the yeast Ccr4 whilst NOT7 and NOT8, which belong to a large family called Caf1, are vertebrate orthologs of the yeast Pop2, respectively [21] [22] [23] . Ccr4 is the key functional deadenylase in yeast 24 , whereas CAF1 was shown to be crucial for deadenylation in nematodes 25 and in Drosophila S2 cells 26 . In human cells, CAF1 is important for microRNA-mediated or small interfering RNA-mediated deadenylation 27 . Recently it was shown that CCR4 is the dominant deadenylase of the human and yeast CCR4-NOT complexes on tails coated with poly(A) binding protein PABPC1 whereas CAF1 is blocked 7, 28 . Other speciesspecific compositional differences relate to the NOT4 subunit, which functions as an E2-dependent RING E3 ligase. It is stably incorporated within the yeast Ccr4-Not but not in Drosophila S2 and human cells 18, [21] [22] [23] 29, 30 . The largely uncharacterized subunits NOT10 and NOT11 are widely conserved in eukaryotes, except for yeast, and interact stably with the NOT1 subunit ( Fig. 1a) 19, 23, 31 .
One long-standing question regarding the CCR4-NOT complex has been that of the role of the non-enzymatic subunits of CCR4-NOT in supporting deadenylation and/or substrate selectivity. Previous results showed that those subunits support targetspecific deadenylation by providing binding sites for factors which recruit CCR4-NOT to specific transcripts 10, 11, 13, 20, [32] [33] [34] , but the question whether other, more direct mechanisms of regulating the nucleases might exist, remained unanswered. Recombinant fission yeast Ccr4-Not complex is strikingly more active and sequence-selective than the Ccr4/Caf1 exonucleases alone 35 . However, the species-specific differences in the subunit composition mean that these results are not directly transferable to the mammalian complex. Hence, in order to investigate the molecular mechanisms of mammalian CCR4-NOT, access to reproducible, active and compositionally defined preparation is essential. However, despite intense efforts, the isolation of fully assembled and compositionally homogeneous mammalian CCR4-NOT complex has not yet been reported. This limits our mechanistic understanding to studies with isolated subunits and subcomplexes 7, 32, 33, [36] [37] [38] [39] [40] [41] .
Here, we describe a procedure to reconstitute the human CCR4-NOT complex using a stepwise assembly of purified recombinant components. Our modular assembly approach permits a simple exchange of variants such as truncated constructs and mutants to rapidly exert full compositional control to test mechanistic hypotheses. We observe that the intact human CCR4-NOT has substantially increased deadenylation activity and sequence selectivity in vitro compared to the exonucleases alone. However, this is not strongly influenced by the sequence composition of the segment preceding the poly(A) tail. Several non-enzymatic modules directly stimulate deadenylation by supporting RNA binding in an apparently redundant manner. Binding of RNA-binding proteins to the CAF40 subunit, in turn, inhibits this intrinsic stimulation of deadenylation. Biochemical reconstitution of human CCR4-NOT presents a strikingly holistic view of this complex in which multiple subunits act in concert to regulate deadenylation.
Results
Production of assembly intermediates of human CCR4-NOT. Functional native CCR4-NOT has been isolated from yeast, Drosophila and human cells 18, 22, 23, 35 . However, isolation of native complexes is challenging, time-consuming and results in compositionally heterogeneous preparations, which are not manipulable or easily tractable for biochemical study. To solve this problem, we focused our approach on in vitro reconstitution with highly purified, recombinant human proteins. First, we generated a single recombinant baculovirus with genes encoding all eight subunits (CCR4a, CAF1, NOT1, NOT2, NOT3, CAF40, NOT10, and NOT11; Fig. 1a ; Supplementary Table 1 ) using the MultiBac system 42, 43 . However, production of the entire complex in insect cells was hampered by low yields and poor subunit stoichiometry. We then revised our approach to co-produce subcomplexes with subsequent reconstitution. We generated a baculovirus comprising the full-length NOT1 together with a minimal set of three full-length proteins (NOT2, NOT3, and CAF40; Supplementary Fig. 1a ) rationalized by observations that these four subunits are mutually stabilizing 33, 34, 39, 44 . A decahistidine tag fused to the N-terminus of the NOT1 scaffold subunit was used for metal affinity purification with typical yields of 4-5 mg per liter of insect cell culture ( Supplementary Fig. 1b ). Remarkably, we observed almost no proteolytic degradation of NOT1, NOT2, and NOT3 despite their size and presence of lowcomplexity regions (Fig. 1b, lane 3) .
The heterodimers of NOT10:NOT11 and the CCR4a:CAF1 exonucleases were recombinantly produced in bacteria (Supplementary Fig. 1c -f). A heterodimer of CCR4a and CAF1 fulllength exonucleases was purified by metal affinity capture followed by size exclusion chromatography and a final highresolution anion exchange step to obtain a complex of 1:1 stoichiometry ( Supplementary Fig. 1c, d ). Previous work indicated that the C-terminal portion of NOT11 (residues 257-498) was sufficient to form a stable trimeric complex with an Nterminal region of NOT1, as well as NOT10 19, 20 . This NOT11 construct including a hexahistidine tag was co-produced in bacteria with NOT10 (residues 25-707) fused to an N-terminal maltose-binding protein (MBP) tag for stability ( Supplementary  Fig. 1e ). Metal affinity capture was followed by proteolytic removal of MBP and subsequent size exclusion chromatography ( Supplementary Fig. 1f ). The purity of the heterodimeric subcomplexes was confirmed by SDS-PAGE ( Fig. 1b which we termed CCR4-NOT FULL (Fig. 1a , c), could be simply and efficiently assembled from three purified subcomplexes by incubating the NOT1:NOT2:NOT3:CAF40 subcomplex produced in insect cells with a two-fold molar excess of CCR4a:CAF1 and NOT10:NOT11 heterodimers on ice for two hours followed by a separation of the mixture of complexes by size exclusion chromatography ( Supplementary Fig. 2a, b ). SDS-PAGE analysis with Coomassie staining confirmed that the reconstituted CCR4-NOT FULL comprised all eight protein subunits in an equimolar stoichiometric ratio, as expected (Fig. 1b, lane 5 ). This was further corroborated by multiangle light scattering coupled with a size exclusion column (SEC-MALS), which indicated that the estimated molecular mass of the peak corresponding to the eightsubunit complex (659 +/− 4 kDa [+/− value indicates technical measurement uncertainty]) was in close agreement with the calculated mass of 647 kDa and the complex was monodisperse in solution ( Fig. 1d ). Thus, we established a simple and reproducible modular strategy to reconstitute biochemically tractable preparations of human CCR4-NOT with a strictly defined subunit composition.
CCR4-NOT FULL is more active and specific than CCR4a:CAF1.
To assess the deadenylation activity of the reconstituted human CCR4-NOT complex we utilized a synthetic RNA substrate of seven nucleotides (5′-UCUAAAU-3′) followed by a polyadenosine tail of 20 nucleotides (A 20 ) and labeled with fluorescein at the 5′ end for visualization ( Fig. 2a ) 37 . The deadenylation reactions then were analyzed on denaturing gels with single nucleotide resolution of products 45 . The CCR4a:CAF1 exonuclease heterodimer demonstrated very low deadenylation activity at an equimolar ratio of enzyme heterodimer to the RNA substrate in a time course experiment, consistent with previous studies 37, 46 (Fig. 2b ). Efficient deadenylation was observed after the ratio of the enzyme complex was increased to be in excess over the substrate ( Supplementary  Fig. 2c ), up to maximal five-fold ( Fig. 2c ). The substrate was degraded first to an intermediate product containing, in addition to the 7-mer body, just one or two As ( Fig. 2c , 16-24 min) and degradation terminated at the 5′-terminal 5′-UCU-3′ trinucleotide ( Fig. 2c , 32-48 min) . This is consistent with previous observations that the CCR4a:CAF1 exonuclease module has a preference rather than strict specificity for adenosine 36, 46 .
In contrast, CCR4-NOT FULL efficiently degraded the poly(A) tail at an equimolar ratio of complex to the substrate ( Fig. 2d vs. b). CCR4-NOT FULL was not only more efficient than the CCR4a: CAF1 heterodimer, but also appeared to be more selective for poly(A), as evident from the stability of the A 1 and A 0 products even following extended incubation ( Fig. 2c , 24-48 min vs. Fig. 2d , 16-48 min) . This suggests that as in yeast the human CCR4-NOT complex exhibits much greater selectivity for poly(A) compared to its constituent exonucleases.
Two non-enzymatic modules suffice to stimulate CCR4a:CAF1. CCR4-NOT FULL is composed of four distinct structural modules: the NOT10:NOT11, CCR4a:CAF1 exonuclease, CAF40 and NOT modules ( Fig. 1a, c) . We asked if we could delineate which modules or even individual subunits may contribute directly towards the increased activity and selectivity of deadenylation.
To this end, in addition to CCR4-NOT FULL, we generated a sixsubunit complex variant, termed CCR4-NOT Δ10:11 , in which the NOT10:NOT11 heterodimer was omitted during the reconstitution procedure (Fig. 1b, c) . The speed and selectivity of deadenylation by CCR4-NOT Δ10:11 appeared very similar to CCR4-NOT FULL ( Fig. 2e vs. d ). This suggests that under the conditions of the assay and with the same substrate the NOT10: NOT11 heterodimer does not stimulate deadenylation of the CCR4-NOT in presence of the other modules.
Next, we tested another six-subunit complex comprising, in addition to the CCR4a:CAF1 full-length exonucleases, only the Cterminal half of NOT1 (residues 1093-2376), CAF40 (residues 19-285), and the minimal constructs of NOT2 (residues 344-540) and NOT3 (residues 607-753). In these constructs, the extensive N-terminal low-complexity regions of NOT2 and NOT3, as well as the NOT3 coiled-coil region, were removed (i.e., the constructs comprise the functional and structural core of the NOT module; Fig. 1c and Supplementary Fig. 2d ). Unlike the larger CCR4-NOT assemblies containing the full-length NOT1 scaffold, all subunits used to reconstitute this complex were produced in bacteria rather than insect cells. Surprisingly, this minimal complex still retained the deadenylation activity almost at the same level as CCR4-NOT FULL (Fig. 2f vs. d) and we termed it CCR4-NOT MINI (Fig. 1c ).
Finally, we reconstituted an assembly in which the CAF40 module comprising CAF40 and one domain from the NOT1 scaffold was the only other module present in addition to the exonuclease module comprising CCR4a, CAF1 and a MIF4G domain of NOT1 (the NOT1 construct consists of residues 1093-1607; Fig. 1c and Supplementary Fig. 2d ). This four-subunit complex lacking the NOT module, which we termed CCR4-NOT CORE , was strikingly less active than CCR4-NOT MINI (Fig. 2g vs. f), but CCR4-NOT CORE was still considerably more active than the CCR4a:CAF1 exonuclease heterodimer ( Fig. 2g vs. b) consistent with previous observations 47 .
In summary of the results presented so far, the systematic compositional dissection of human CCR4-NOT revealed that in addition to the CCR4a:CAF1 exonucleases, the non-enzymatic CAF40 and NOT modules are together necessary and sufficient to fully stimulate deadenylation in vitro. In contrast, the NOT10: NOT11 module did not provide substantial additional stimulation. Importantly, in all the CCR4-NOT complexes we compared, the CCR4a:CAF1 exonucleases were purified and incorporated into larger assemblies in an identical manner. This strategy ensured that activity assays were consistently reproducible between different, independently purified batches of complexes.
At 1 µM concentration the NOT10:NOT11 heterodimer is the only subcomplex to bind the 7-mer-A 20 RNA under the nonequilibrium conditions of electrophoretic mobility shift assays (EMSA) (Fig. 2h ). The binding of the CAF40 module was detectable only at 25 µM ( Supplementary Fig. 2e ). Although we did not observe binding of other modules under these assay conditions, we cannot rule out that these interactions occur in the context of the intact complex. We then performed UV crosslinking experiments that provide further evidence of interactions of the labeled poly(U) RNA with the CCR4-NOT FULL , the NOT10:NOT11 heterodimer and, to a lesser degree, also with MBP-tagged CAF40 and the nuclease module (Supplemental Fig. 2f ). This indicates that the NOT10:NOT11 and CAF40 modules can directly interact with the RNA, which implies that they may contribute to improved substrate binding. Finally, we show that CCR4-NOT FULL binds preferentially to poly(U) and poly(G) sequences compared to poly(A) and poly(C) under the EMSA conditions ( Supplementary Fig. 2g ).
Distinct activities of CCR4a and CAF1 in CCR4-NOT FULL . The presence of two seemingly redundant nucleases in the CCR4-NOT complex raises the interesting question as to whether they are indeed redundant or have rather distinct functions. In S. pombe, single deactivating mutations of either Ccr4 or Caf1 exonuclease only mildly impaired the activity of the intact Ccr4-Not in vitro and complete deadenylation block was observed only when both catalytic mutants were combined 35 . However, the human CCR4a:CAF1 heterodimer stabilized by the accessory factor BTG2 was reported to be inactive in vitro when either of the exonucleases is mutated 48 .
To examine the individual contributions of CCR4a and CAF1 we reconstituted heterodimers where one of the enzymes contained an inactivating catalytic mutation: CCR4a E240A :CAF1 and CCR4a:CAF1 D40A 35,37,49 . We observed that, in contrast to the reported findings in the presence of BTG2 48 , the catalytic inactivation of either CAF1 or CCR4a had little impact on the deadenylation pattern compared to the wildtype CCR4a:CAF1 ( Fig. 3a, b vs. 2c). CCR4a E240A :CAF1 was slightly less efficient than CCR4a:CAF1 D40A ( Fig. 3 b vs. a, 8-24 min). However, there was a clear difference in sequence selectivity in the mutant context with CCR4a:CAF1 D40A degrading the substrate to a stable A 1 product (5′-UCUAAAUA-3′) whereas CCR4a E240A :CAF1 efficiently degraded to the 5′-UCU-3′ trinucleotide (Fig. 3a , 32-48 min vs. 3 b, 40-48 min). Thus, CCR4 appears to be more specific for adenosine nucleotides compared to CAF1 37 .
We then asked if CCR4a retains its higher activity and selectivity compared to CAF1 when incorporated into CCR4-NOT FULL . Intriguingly, CCR4a:CAF1 D40A showed slightly reduced activity in the context of CCR4-NOT FULL compared with wildtype ( Fig. 3c ARTICLE sequence selectivity than wildtype CCR4-NOT FULL as the A 1 product was remarkably stable over the deadenylation time course (Fig. 2d , 24-48 min vs. 3c, 32-48 min). Inactivating CCR4a in the CCR4-NOT FULL , however, drastically reduced the deadenylation efficiency compared to wildtype ( Fig. 3d vs. 2d) or CCR4-NOT FULL reconstituted with CCR4a:CAF1 D40A (Fig. 3d vs. c). Importantly, catalytic inactivation of CCR4a resulted in a much more severe deadenylation defect in the context of CCR4-NOT FULL than in the isolated exonuclease heterodimer ( Fig. 3d vs. b) suggesting that the non-enzymatic subunits modulate distinct exonuclease activities.
We have also reconstituted the CCR4-NOT Δ10:11 and CCR4-NOT MINI complexes with the CCR4a E240A :CAF1 and CCR4a: CAF1 D40A exonuclease mutants. The same overall pattern where CCR4a was more active and selective than CAF1 on synthetic substrates was also observed in these complexes ( Supplementary  Fig. 3a-e ). Thus, the distinct properties of CCR4a and CAF1 appear not to alter in response to the non-enzymatic subunit composition. We have also tested a CCR4a E240A :CAF1 D40A complex where both enzymes were inactivated, and incorporated these inactive exonucleases into CCR4-NOT FULL and CCR4-NOT MINI . None of these complexes were active, which suggests our purification procedures were effective in removing any contaminant nuclease activity ( Supplementary Fig. 3f-h) .
Taken together, these results support a model in which CCR4a rather than CAF1 makes the dominant contribution towards the activity and specificity of deadenylation in the intact human CCR4-NOT complex in vitro and in absence of other factors.
Peptide motifs compete with RNA for binding to CAF40. The CAF40 subunit is positioned next to CCR4a:CAF1 on the NOT1 scaffold ( Fig. 1a) where it serves as a binding platform not only for nucleic acids in vitro ( Supplementary Fig. 2e , f) 41 but also for the α-helical CAF40-binding motifs (CBMs) of metazoan NOT4 50 , as well as the Drosophila melanogaster (Dm) proteins Bag-of-marbles (Bam; Supplementary Fig. 4a ) 20 and Roquin 13 . To confirm that the CAF40 subunit retains the same binding to the CBMs in the context of the CCR4-NOT FULL and CCR4-NOT MINI complexes, we carried out pulldown assays with MBPtagged Bam CBM and the Roquin C-terminal region (Supplementary Fig. 4b, c ).
Protein-protein and protein-RNA interactions on CAF40 are shared via a common surface 13, 20, 41, 50 , and consequently, they are likely to be mutually exclusive. To test this, we initially set out to test competition between RNA and protein binding by CAF40. We selected the CBM of Bam as a candidate deadenylation antagonist due to its nanomolar affinity for CAF40 and structurally characterized binding mode 20 ( Supplementary  Fig. 4d ). Indeed, MBP-tagged Bam CBM WT efficiently prevented CAF40 from RNA binding in an EMSA (Fig. 4a) . In contrast, a Bam CBM containing amino acid substitutions L17E and M24E designed to disrupt binding to CAF40 ( Supplementary Fig. 4d ) 20 , which we termed Bam CBM MUT , had almost no effect on RNA binding by CAF40 ( Fig. 4a ).
Then, we devised an assay to investigate the impact of Bam CBM WT on the CAF40-mediated stimulation of deadenylation. We chose to initially test it on CCR4-NOT CORE as this complex is more active than the exonucleases and the CAF40 module is the only non-enzymatic module present.
The deadenylation activity of CCR4-NOT CORE was strongly reduced when we titrated increasing amounts of MBP-tagged Bam CBM WT (Fig. 4b , lanes 5-8) compared to the MBP control ( Fig. 4b, lanes 1-4) . Strong inhibition was also evident in a time course assay in the presence of an almost saturating concentration of the Bam CBM WT , equivalent to 50-fold molar excess over CAF40 (Fig. 4c , left and middle panels). Indeed, the activity of CCR4-NOT CORE with this concentration of Bam CBM WT was reduced almost to the level of the CCR4a:CAF1 heterodimer alone ( Fig. 4c , middle panel vs. Fig. 2b ). The activity of the exonuclease heterodimer alone was not inhibited by Bam CBM WT ( Supplementary Fig. 4e ). Importantly, the activity of CCR4-NOT CORE was not affected when we added an equivalent molar excess of Bam CBM MUT or with the MBP control ( Fig. 4c , left and right panels). This suggests that deadenylation inhibition is directly correlated to high-affinity binding of this linear peptide motif to CAF40.
The NOT10:NOT11 module compensates for CAF40 unavailability. To assess if the Bam CBM can inhibit if the other stimulatory sites of the CCR4-NOT complex are available, we tested its effect on the deadenylation ability of our larger assemblies. Initially, we observed that CCR4-NOT MINI was also progressively inhibited by increasing amounts of Bam CBM (Fig. 4d ), but not as efficiently as CCR4-NOT CORE (Fig. 4b ), suggesting that the NOT module can partially compensate for the loss of deadenylation stimulation by CAF40. CCR4-NOT FULL was even more (Fig. 2c) , and the CAF1 D40A mutation (a) improves the selectivity of the exonuclease heterodimer for adenosine. c, d Deadenylation assays with equimolar concentrations (50 nM) of 7-mer-A 20 RNA and CCR4-NOT FULL complexes with the catalytically inactivating mutations in CAF1 (c) and CCR4a (d), respectively. The CAF1 D40A mutation mildly decreases deadenylation activity and leads to increased adenosine specificity compared to wildtype (Fig. 2d Unlike with CCR4-NOT MINI , the activity of CCR4-NOT FULL was only slightly affected during titration with Bam CBM WT (Fig. 4e ). This difference between the two complexes suggests that the NOT10: NOT11 module is primarily responsible for the resistance of CCR4-NOT FULL against the inhibition by the Bam CBM. This was confirmed by the observation that in presence of Bam CBM WT , the deadenylation activity of CCR4-NOT Δ10:11 was significantly inhibited compared to the CCR4-NOT FULL and rather resembled the situation in CCR4-NOT MINI (Fig. 4f) . Given that CAF40 is conserved and in an assumed spatial proximity to the exonucleases, we suggest that CAF40 provides the principal stimulatory surface. If this is blocked by a linear motif from an interacting partner, then the NOT and NOT10: NOT11 modules can potentially compensate.
Multiple CCR4-NOT interactors can inhibit deadenylation. To determine if the deadenylation inhibition via the CBM is unique to Bam or whether CBMs from other RNA-binding recruitment factors can also impact on CCR4-NOT activity, we tested an extended C-terminal fragment of human Roquin1 (Roq-C), which binds directly to the CAF40 subunit and the NOT module ( Supplementary Fig. 4f ) 13, 20 , as well as a CBM from the Cterminus of NOT4 which binds to the same surface as the Bam CBM, but in a structurally unrelated manner ( Supplementary  Fig. 4g ) 50 . In a series of deadenylation time courses, where we systematically tested the effect of all three MBP-tagged peptides (Bam CBM WT , Roq-C, and NOT4 CBM) on CCR4-NOT MINI (Fig. 5a ), CCR4-NOT FULL (Fig. 5b ) and CCR4-NOT Δ10:11 (Fig. 5c ), we observed that peptide motifs from all three factors inhibit CCR4-NOT-mediated deadenylation in vitro. However, the extent of inhibition varied among the complexes. The complexes lacking the NOT10:NOT11 heterodimer, CCR4-NOT Δ10:11 and CCR4-NOT MINI , were strikingly more sensitive to the inhibition by the peptides compared to the CCR4-NOT FULL . Taken together, these results show that multiple interaction partners of the CCR4-NOT complex can repress deadenylation via direct binding to CAF40 and the NOT10:NOT11 module compensates by restoring deadenylation stimulation.
3′-UTR length but not composition affects deadenylation. The interactions of several stimulatory modules with RNA suggested that longer substrates may engage several stimulatory surfaces at the same time. This would stabilize the enzyme-substrate complex and lead to more efficient deadenylation. To test this, we performed deadenylation assays using a substrate with an extra 13 randomly chosen nucleotides, which are predicted to be unstructured, 5′ of the 7-mer-A 20 ( Supplementary Table 4 ). This RNA substrate interacts stably with the CCR4-NOT FULL complex, as well as the NOT10:NOT11 heterodimer under the EMSA conditions ( Supplementary Fig. 5a ), and at higher concentrations with the CAF40 module ( Supplementary Fig. 5b ), similar to the shorter 7-mer-A 20 substrate ( Fig. 2h and Supplementary Fig. 2e ). We observed an enhanced deadenylation activity of CCR4-NOT FULL on this 13 + 7-mer-A 20 substrate compared to 7-mer-A 20 (Fig. 6a, 16 min vs. 2d, 48 min, and Fig. 6d ). This result is in contrast to the reported situation in fission yeast where the length upstream of the poly(A) did not significantly influence activity 35 . At the same time, the CCR4-NOT complex did not degrade this substrate beyond the first two consecutive non-A nucleotides, consistent with the notion that the high level of selectivity for adenosine is not influenced significantly by the overall length of the substrate. Strikingly, we did not observe a similar enhancement with the longer substrate on the activity of the CCR4a:CAF1 heterodimer ( Fig. 6b vs. 2c ). Furthermore, the absence of the NOT10:NOT11 module reduced the deadenylation activity on the longer substrate only slightly (Fig. 6c vs. a, and Supplementary  Fig. 5c ).
To assess whether the sequence of the region preceding the poly(A) influences deadenylation by CCR4-NOT FULL , we performed deadenylation assays using four different substrates, each with 20 nucleotides upstream of A 20 ( Supplementary Table 4) . Surprisingly, the differences between three substrates with unstructured 5′ regions were not very pronounced (Fig. 6d, e , Supplementary Fig. 5d ), suggesting that the sequence composition of 3′-UTR does not significantly influence deadenylation. Introduction of a short stem-loop structure led to an initial decrease in the rate of deadenylation but the reaction still proceeded to completion (Fig. 6f vs. d, e ). This suggests that the presence of secondary structure in the 3′-UTR is not a critical determinant of deadenylation efficiency.
The CCR4-NOT complex is a conformationally flexible assembly. We used negative stain electron microscopy (EM) to characterize the particle shape and dimensions of CCR4-NOT FULL . This revealed many particles of different size and shape ( Supplementary Fig. 6a ). Their size heterogeneity and globular appearance suggested they were isolated subunits or subcomplexes. Localized particle clustering further indicated that CCR4-NOT FULL disassembles when stained with acidic uranyl formate. To stabilize complexes for EM, we employed mild crosslinking using glutaraldehyde during sucrose density gradient centrifugation 51 . This markedly reduced nonspecific aggregation and complex disassembly resulting in a more homogeneous particle size distribution ( Supplementary Fig. 6b ). The average length of a particle was approximately 22-24 nm in the longest direction, consistent with the reported dimensions observed by negative stain EM for the yeast Ccr4-Not complexes 52, 53 . However, particle shape and appearance indicates that CCR4-NOT FULL adopts not one single conformation but rather a continuum of many different conformations, which means that many of the subunits and modules may be able to locate in close spatial proximity.
Discussion
The human CCR4-NOT complex was recently shown to be the principal mediator of deadenylation 7 . Here, we describe the production of a fully recombinant human CCR4-NOT complex comprising all eight subunits, with only the NOT11 subunit containing a significant truncation of the unstructured Nterminal region. Through a modular reconstitution approach, we systematically characterized the contribution of nonenzymatic modules towards deadenylation.
We observed that the intact complex is strikingly more active compared to the isolated CCR4a:CAF1 heterodimer, consistent with observations in fission yeast 35 . The CCR4-NOT complex is also much more sequence-specific as evident by stalling following efficient shortening of the substrate poly(A) tail. Previously it was shown that recombinant CCR4b is significantly more selective towards polyadenosine in synthetic substrates compared to CAF1 36, 37, 54 . Our studies with mutant nucleases incorporated into the CCR4-NOT indicated that CCR4a is principally responsible for sequence selectivity and activity, whereas CAF1 was rather inactive in three distinct compositional variants of the CCR4-NOT under the assay conditions. This contrasts markedly with the fission yeast complex where Caf1 and Ccr4 catalytic mutants had almost identical deadenylation profiles 35 . CCR4a and CAF1 were reported to be functionally distinct depending on whether the poly(A) tail is coated with the poly(A)-binding protein (PABPC1) 7, 35 . Our results indicate that the functional distinction between CCR4a and CAF1 exists also in the absence of PABPC1.
The activity of the fission yeast Ccr4-Not was shown to depend on the sequence and the secondary structure content of the 3′-UTR but not its length. It was thus proposed that the Ccr4-Not has an intrinsic ability to recognize and respond to the sequence and/or structure context upstream of the poly(A) tail 35 . Human CCR4-NOT, in contrast, showed a strong dependence on the length of the 3′-UTR segment. Since the exonuclease module does not bind the substrate well, the purpose of multiple independent RNA-binding sites on spatially distinct modules may be to strengthen the interaction of the complex with its substrate via avidity effects and thereby improve deadenylation efficiency. Furthermore, our data indicate that the human CCR4-NOT is not selective at the sequence level for 3′-UTR and deadenylation activity is not significantly impacted by the secondary structure. This is consistent with a view that the CCR4-NOT may be more reliant on extrinsic factors for 3′-UTR discrimination than the yeast complex. This may increase the potential for a very fine, transcript-specific regulation of gene expression necessary in multicellular organisms. We observed that the CCR4-NOT-mediated deadenylation is only efficiently terminated once a stretch of more than two nonadenosine residues is encountered by the complex. The CCR4-NOT thus has an intrinsic preference for poly(A), which is enhanced by the non-enzymatic subunits and is independent of the sequence context of the 3′-UTR. Collectively, our findings support a view of the human CCR4-NOT where non-enzymatic subunits serve not only to enhance the exonuclease activity but to exquisitely tune it for the purpose of poly(A) shortening and to minimize nonspecific RNA degradation.
We observed that at least three independent sites on the human CCR4-NOT act in concert to stimulate deadenylation. The CAF40 subunit binds RNA directly via a conserved surface and is sufficient to strongly stimulate activity. CAF40 is proximal to the exonuclease module, which does not bind substrates stably, and thus CAF40 may stimulate deadenylation through improved substrate binding or through optimized orientation of the RNA for degradation.
In addition to the CAF40 module, the structural core of the NOT module, consisting of the NOT2 and NOT3 subunits, as well as the C-terminal domain of NOT1, is necessary and sufficient to achieve full stimulation in vitro. In our binding assays, the human NOT module does not bind RNA directly unlike the yeast NOT module, which was shown to bind nucleic acid in vitro 44 . The NOT module is critical for the stability of CCR4-NOT in Drosophila S2 cells 39 and we suggest this role is conserved in the human complex thus aiding its activity but the precise mechanistic contribution remains unclear at present.
The NOT10:NOT11 module provides the third potent stimulatory site. The module is conserved in many eukaryotes, with the exception of unicellular yeasts, but its function remains unknown although it appears to serve an important function in mammals as Cnot10 deficiency in mice causes embryonic lethality 55 . It binds RNA directly and with the highest relative affinity of all modules tested in this study (Fig. 2h) . Thus, we suggest that NOT10:NOT11 stimulates deadenylation through direct stabilization of the substrate RNA but only under distinct conditions where the principal stimulatory CAF40 surface may not be available for RNA binding.
Taken together, we propose a mechanistic model in which RNA-binding surfaces on distinct modules cooperate to enhance interaction with the substrate to elicit efficient deadenylation. Such interactions may also exploit the inherent structural Fig. 6 The length of the segment preceding the poly(A) tail but not its sequence impacts on deadenylation. a Deadenylation assay with the CCR4-NOT FULL complex and the 13+7-mer-A 20 RNA substrate in equimolar ratio (50 nM) . This substrate contains an additional unstructured 13-mer segment 5′ to the 7mer-A 20 RNA. The deadenylation of this substrate is markedly enhanced compared to the 7-mer-A 20 substrate (Fig. 2d ) and did not proceed beyond the first two consecutive non-A nucleotides. b Deadenylation assay with the same 13+7-mer-A 20 substrate (50 nM) and a five-fold molar excess of the CCR4a:CAF1 exonuclease heterodimer (250 nM). The rate of deadenylation does not differ to that with the 7-mer-A 20 substrate indicating that the exonuclease heterodimer does not discriminate between these substrates (Fig. 2c) . c Deadenylation assay with the CCR4-NOT Δ10:11 complex and the 13+7-mer-A 20 RNA substrate in equimolar ratio (50 nM). d Deadenylation assay with the CCR4-NOT FULL complex and the 13+7-mer-A 20 substrate (both 50 nM) with higher resolution of the early time points compared to a. e Deadenylation assay with the CCR4-NOT FULL complex and a 20-mer-A 20 substrate where the seven nucleotides immediately preceding the poly(A) tail were different from the 13+7-mer-A 20 substrate in equimolar ratio (50 nM). f Deadenylation assay with the CCR4-NOT FULL complex and the 13-SL-7-mer-A 20 substrate containing a short stem-loop structure within the 20nucleotide region upstream of A 20 in equimolar ratio (50 nM) (see also Supplementary Table 4 ). Source data are provided as a Source Data file flexibility of CCR4-NOT to position the mRNA substrate in an optimal conformation (Fig. 7a ).
Linear motifs from several mRNA-binding proteins can bind to the highly conserved nucleic acid binding site on CAF40 to compete with RNA binding and interfere with deadenylation stimulation. The long-standing notion of targeted deadenylation by the CCR4-NOT is a unidirectional one in which CCR4-NOT acts on bulk mRNA and is repurposed toward specific mRNA targets by protein factors. Our biochemical data suggests that blocking an RNA-binding surface on CAF40 by recruitment factors may reduce nonspecific substrate binding and bulk deadenylation but this model remains to be tested in vivo (Fig. 7b ). Our findings indicate that there is some RNA-binding redundancy in the CCR4-NOT modules. Recruitment factors such as GW182 33 , TTP 56 , and Roquin 13 bind to several CCR4-NOT subunits through extended motifs. Multiple recruitment and regulatory events could perhaps occur simultaneously on the multisubunit CCR4-NOT and access to specific stimulatory sites may be regulated in specific contexts. An important future goal is to understand how the conformational dynamics of the CCR4-NOT complex are influenced through combinatorial control from multiple regulatory inputs in response to stimuli to ultimately redirect the gene expression program of specific targets.
In conclusion, our compositional dissection of the human CCR4-NOT reveals that many parts of this multisubunit complex act together and intrinsically modulate each other to coordinate the shortening of poly(A) tails. We propose a mechanistic model of allosteric and cooperative stimulation of the exonucleases where several non-enzymatic modules mediate interactions with the RNA substrate. Means of producing the recombinant and biochemically tractable intact human CCR4-NOT will facilitate the future studies of targeted deadenylation, translational repression, and co-translational decay.
Methods
DNA constructs. For expression of the NOT1:NOT2:NOT3:CAF40 complex ( Supplementary Fig. 1a and 7a) , full-length NOT1 was amplified from a human cDNA library, and sequences encoding an N-terminal His 10 (fused to NOT1 via a TEV protease site) and two consecutive C-terminal StrepII tags were added during PCR. The DNA sequence encoding full-length CAF40 was amplified from the same cDNA library. Then, the NOT1 and CAF40 PCR products were fused together, each with a downstream SV40 poly(A) signal and an upstream polyhedrin promoter, into a single cassette by overlap extension PCR, and this cassette was inserted between the SalI and ScaI restriction sites into the pACEBac1 vector backbone ( Supplementary Fig. 7b ). The oligonucleotide primers used in this study are listed in Supplementary Table 5 .
cDNA encoding full-length NOT2 was also amplified from the cDNA library, and the cleaved PCR product inserted between the XhoI and NcoI restriction sites of the pIDK plasmid. Amplified cDNA encoding full-length NOT3 was inserted in the KpnI restriction site of the pIDK plasmid. Following this, the NOT2 cassette including the upstream polyhedrin promoter and the downstream SV40 poly(A) signal was amplified from the pIDK-NOT2 plasmid and inserted into the ClaI restriction site of pIDK-NOT3 to create the pIDK-NOT2-NOT3 plasmid ( Supplementary Fig. 7b ).
Finally, the pACEBAC-NOT1-CAF40-NOT2-NOT3 bacmid was created in vitro by Cre-Lox recombination using Cre recombinase (New England Biolabs) with 200 fmol of pACEBac-NOT1-NOT9 and 300 fmol pIDK-NOT2-NOT3 in the reaction.
cDNA encoding full-length CCR4a was inserted into the pMCSG19c plasmid vector 57 between KpnI and BamHI restriction sites ( Supplementary Fig. 7c ). In this vector an insert is fused in-frame with a gene encoding maltose-binding protein (MBP) with an adjacent TVMV protease cleavage site. Low-level production of encoded TVMV protease from the same plasmid cleaves the fused MBP in vivo resulting in a CCR4a protein construct with an N-terminal His 6 -tag followed by the TEV protease recognition site.
CAF1 cDNA fused to an N-terminal TEV site was inserted between the BamHI and HindIII restriction sites of the pET28b plasmid (Merck). To improve the stability of CAF1, a SUMO3 tag with an N-terminal His 6 tag was inserted between NdeI and BamHI restriction sites, resulting in a SUMO-His 6 -CAF1 fusion construct cleavable by TEV protease ( Supplementary Fig. 7c ).
The NOT10:NOT11 heterodimer for reconstitution was co-expressed from two plasmids: cDNA encoding NOT10 (residues 25-707) was inserted between the XhoI and BamHI restriction sites of the pnYC-pM plasmid 58 , resulting in an MBPtagged fusion construct cleavable by HRV-3C protease ( Supplementary Fig. 7d) . The NOT11 C-terminal construct (residues 257-498) was inserted between the same restriction sites of the pnEA-vH plasmid 58 , and the resulting C-terminally His 6 -tagged construct was cleavable by TEV protease (Supplementary Fig. 7d ).
For expression of the tetramer which serves as a scaffold of the CCR4-NOT MINI complex ( Supplementary Fig. 8a) , two plasmids were used. MBP-tagged NOT1 (residues 1093-2376) encoded on a plasmid of the pnYC backbone which has been described before 13 (Supplementary Fig. 8b) . A tricistronic plasmid encoding for MBP-tagged NOT2 (residues 344-540), His 6 -tagged NOT3 (residues 607-753) and
Bulk, nonspecific deadenylation Fig. 7 A proposed mechanistic model for the switch from bulk to targeted deadenylation. a The CCR4-NOT complex possesses intrinsic affinity towards nucleic acids which allows it to bind to and deadenylate bulk mRNAs in a manner independent of the sequence of the RNA. In addition to the active sites of the nucleases, also the CAF40 module, the NOT module, and the NOT10:NOT11 module can directly interact with the substrate and contribute to a different extent to the stimulation of deadenylation, with CAF40 being the dominant stimulatory site under the conditions of our in vitro assays. b Upon stimulation, RNA-binding proteins (RBPs) can recruit the CCR4-NOT complex to specific transcripts via direct protein-protein interactions and trigger the preferred deadenylation of those transcripts. In addition, RBPs carrying a CAF40-binding motif can mask the RNA-binding site on CAF40, thereby gaining further competitive advantage for deadenylation of their bound mRNA over other, nonspecific transcripts in the cytoplasmic mRNA pool NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11094-z ARTICLE His 6 -tagged CAF40 (residues 19-285) was constructed based on the pnEA architecture 58 . All tags were cleavable by HRV-3C protease apart from the His 6 tag fused to NOT3 which was non-cleavable ( Supplementary Fig. 8b) .
Two plasmids were used for the expression and purification of the NOT1: CAF40 complex serving as the base for reconstitution of the CCR4-NOT CORE complex ( Supplementary Fig. 8c ). cDNA encoding for NOT1 (residues 1093-1607) was inserted between the XhoI and BamHI restriction sites of the pnYC-pM plasmid backbone. CAF40-encoding cDNA (residues was inserted between the XhoI and BamHI restriction sites of a pnEA plasmid which does not encode any affinity tags ( Supplementary Fig. 8d ).
For expression of MBP-tagged CAF40, cDNA encoding CAF40 residues 18-293 was inserted between the XhoI and BamHI restriction sites of the pnEA-pM plasmid 58 .
The DNA constructs for the production of the individual CCR4-NOT modules (the CAF40 module comprising NOT1 residues 1351-1588 and CAF40 residues 19-285, and the NOT module core comprised of NOT1 residues 1833-2361, NOT2 residues 350-540 and NOT3 residues 607-748), MBP-tagged Drosophila Bam CBM and MBP-tagged Hs Roquin1 CBM have been described before, as well as the detailed description of expression and purification of these constructs 11, 13, 20, 33 .
Site-directed mutagenesis was carried out according to modified QuickChange TM protocol 59 . All the plasmid constructs and mutants used in this study were confirmed by DNA sequencing and are listed in Supplementary Table 2 .
Baculovirus production. Recombined multi-plasmid vectors were transformed into chemically competent DH10EmbacY cells (a kind gift from Imre Berger). Positive baculovirus genome integrands were selected using blue/white screening on LB-agar plates containing IPTG and Bluo-Gal (Gold Biotechnology) with 25 µg/ml kanamycin, 10 µg/ml tetracycline, 34 µg/ml chloramphenicol, and 10 µg/ml gentamicin. Two white colonies were used to inoculate 5 ml LB cultures with all four antibiotics at the same concentrations and cultured at 37°C overnight. Bacmid DNA was purified by alkaline lysis with buffers P1, P2, and N3 (Qiagen). Following isopropanol precipitation, pellets were washed with ice-cold 70% (v/v) ethanol and centrifuged at 4°C before being resuspended in sterile, milliQgrade water.
Sterile 1-5 µg bacmid DNA was transfected into a standard sterile 6-well plate (Greiner) with technical replicates of 1.0 × 10 6 adherent Sf21 cells (a kind gift from Imre Berger) using Fugene HD reagent (Promega). The supernatant containing the initial V 0 low-titer baculovirus was collected once at least 50% of cells were fluorescent due to the expression of the YFP marker. Suspension cultures at 1.0 × 10 6 cells/ml were infected with approximately 10% (v/v) V 0 virus stock. A working V 1 stock of baculovirus was collected 72 h after infection. Cells were cultured in Sf900II serum-free medium (Thermo Fisher Scientific) without any supplements.
Purification of the CCR4a:CAF1 exonuclease heterodimer. Full-length CCR4a and CAF1 were co-expressed in E. coli BL21(DE3) Star cells (Thermo Fisher Scientific) in LB medium at 20°C as fusion proteins carrying N-terminal His 6 and His 6 -SUMO tags, respectively. Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) in a buffer containing 50 mM potassium phosphate pH 7.5, 300 mM NaCl and 25 mM imidazole supplemented with complete EDTA-free protease inhibitors, 5 µg/ml DNaseI and 1 mg/ml lysozyme. The proteins were isolated from the cleared lysate by binding to a Nickel-charged HiTrap IMAC column (GE Healthcare) and eluted from the column by a linear gradient to the same buffer supplemented with 500 mM imidazole. Both tags were then cleaved off overnight by incubation with recombinant TEV protease while dialyzing against a buffer containing 30 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 2 mM DTT. Then, the CCR4a:CAF1 heterodimer was eluted on a Superdex 200 26/600 size exclusion chromatography column (GE Healthcare) equilibrated in a buffer containing 10 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 2 mM DTT. Finally, the NaCl concentration was diluted to 75 mM, and the complex bound to a Source 15Q column (GE Healthcare) was subsequently eluted by a linear gradient to buffer containing 10 mM HEPES/NaOH pH 7.5, 1000 mM NaCl and 2 mM DTT. The eluted CCR4a:CAF1 complex was concentrated to 6-7 mg/ml, flash-frozen and stored at −80°C. Mutant variants of CCR4a:CAF1 were purified in the same way as the wild-type heterodimer. The CCR4a:CAF1 dimer purified following this scheme was used for reconstitution of all larger complexes (CCR4-NOT FULL , CCR4-NOT Δ10:11 , CCR4-NOT MINI , and CCR4-NOT CORE ).
Purification of the NOT10:NOT11 heterodimer. Both proteins were co-expressed in E. coli BL21(DE3) Star cells in LB medium at 20°C as fusion proteins carrying C-terminal His 6 (NOT11, residues 257-498) and N-terminal MBP (NOT10, residues 25-707) tags, respectively. Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) in a buffer containing 50 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 25 mM imidazole supplemented with complete EDTA-free protease inhibitors, 5 µg/ml DNaseI and 1 mg/ml lysozyme. The proteins were isolated from the cleared lysate by using a nickel-charged HiTrap IMAC column (GE Healthcare) and eluted by a linear gradient to a buffer containing 50 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 500 mM imidazole. Subsequently, the tags were cleaved off overnight by incubation with recombinant HRV-3C and TEV proteases, while dialyzing against a buffer containing 50 mM HEPES/NaOH pH 7.5, 300 mM NaCl, 10% (v/v) glycerol and 2 mM DTT. Then, the NOT10:NOT11 heterodimer was eluted on a Superdex 200 26/600 size exclusion chromatography column (GE Healthcare) equilibrated in a buffer containing 10 mM HEPES/NaOH pH 7.5, 300 mM NaCl, 10% (v/v) glycerol and 2 mM DTT. The NOT10:NOT11 heterodimer was concentrated to 6-7 mg/ml, flash-frozen and stored at −80°C.
MBP-CAF40 purification. CAF40 (residues 18-293) was expressed in E. coli BL21 (DE3) Star cells in LB medium at 20°C with an N-terminal MBP tag. Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) in a buffer containing 50 mM HEPES/NaOH pH 7.5, 500 mM NaCl, 10% (v/v) glycerol, and 2 mM DTT. The complex was isolated from the crude lysate using amylose resin (New England Biolabs) and eluted with lysis buffer supplemented with 30 mM D-(+)-maltose. The eluted protein was diluted to reach a final concentration of 100 mM NaCl. This was then applied on a 5 ml heparin column (GE Healthcare) and eluted with a linear gradient to 1 M NaCl. This was followed by size exclusion chromatography on a Superdex 200 26/60 column (GE Healthcare) equilibrated in a buffer containing 10 mM HEPES/NaOH pH 7.5, 200 mM NaCl, 10% (v/v) glycerol, and 2 mM DTT. The protein was concentrated to approximately 25 mg/ml.
Reconstitution of CCR4-NOT FULL and CCR4-NOT Δ10:11 complexes. Sf21 insect cells were grown at 27°C to a density of 2.0 × 10 6 cells/ml in Sf900II medium (Thermo Fisher Scientific) and infected with recombinant NOT1:NOT2:NOT3: CAF40 baculovirus stock (1:100 v/v). The cells were harvested by centrifugation 48 h after they stopped dividing and pellets stored at −80°C.
Pellets of insect cells expressing the NOT1:NOT2:NOT3:CAF40 tetramer were thawed, resuspended in lysis buffer (50 mM HEPES/NaOH pH 7.5, 500 mM NaCl, 10 mM potassium phosphate pH 7.5, 50 mM imidazole, 5 µg/ml DNAseI) and lysed by sonication (Branson Sonifier; level 2; 20% output; 1 min). The lysate was cleared by centrifugation (15 min at 12,500 × g) and filtered through 0.45 µm and 0.22 µm syringe-driven filters (Millipore). The cleared and filtered lysate was applied to a nickel-charged 1 ml HiTrap IMAC column (GE Healthcare) and the bound complex eluted by a linear gradient to a buffer containing 50 mM HEPES/ NaOH pH 7.5, 300 mM NaCl, 10 mM potassium phosphate pH 7.5 and 500 mM imidazole.
For reconstitution of CCR4-NOT FULL , the NOT1:NOT2:NOT3: CAF40 subcomplex was mixed in a 1:2:2 molar ratio with CCR4a:CAF1 (wildtype or mutants) and NOT10:NOT11 complexes. The mixture was then incubated on ice for 2 h to assure the association of the subcomplexes with each other, and then the assembled complex was separated from the excess of CCR4a:CAF1 and NOT10:NOT11 heterodimers by size exclusion chromatography on a Sephacryl HR-300 26/60 column (GE Healthcare) equilibrated in a buffer containing 10 mM HEPES/NaOH pH 7.5, 200 mM NaCl, and 2 mM DTT. The complex was concentrated to approximately 1 mg/ml, and for deadenylation assays, it was subsequently aliquoted, flash-frozen and stored at −80°C.
Procedures were identical for the reconstitution of the CCR4-NOT Δ10:11 complex with the difference that the NOT10:NOT11 heterodimer was omitted from the mixture of subcomplexes.
Reconstitution of the CCR4-NOT MINI complex. MBP-tagged NOT1 (residues 1093-2371), MBP-tagged NOT2 (residues 344-540), His 6 -tagged NOT3 (residues 607-753) and His 6 -tagged CAF40 (residues 19-285) were co-expressed in E. coli BL21(DE3)Star cells in LB medium at 20°C. Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) in a buffer containing 50 mM potassium phosphate pH 7.5 and 300 mM NaCl supplemented with complete EDTA-free protease inhibitors, 5 µg/ml DNaseI and 1 mg/ml lysozyme. The complex was isolated from the crude lysate using amylose resin (New England Biolabs) and eluted with lysis buffer supplemented with 25 mM D-(+)-maltose. The tags were removed by cleavage with HRV-3C protease.
Subsequently, a two-fold molar excess of purified CCR4a:CAF1 heterodimer (wildtype or mutants) was added and the mixture incubated for two hours. Finally, the assembled complex was separated from the affinity tags and the excess of CCR4a:CAF1 by size exclusion chromatography on a Superdex 200 26/60 column (GE Healthcare) equilibrated in a buffer containing 20 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 2 mM DTT. The complex was concentrated to approximately 1 mg/ml.
Reconstitution of the CCR4-NOT CORE complex. The heterodimer of NOT1 (residues 1093-1607) and CAF40 (residues 19-285) was co-expressed in E. coli BL21(DE3) Star cells in LB medium at 20°C with N-terminal MBP and His 6 tags, respectively. Cells were lysed using an Emulsiflex-C3 homogenizer (Avestin) in a buffer containing 50 mM potassium phosphate pH 7.5 and 300 mM NaCl supplemented with complete EDTA-free protease inhibitors, 5 µg/ml DNaseI and 1 mg/ml lysozyme. The complex was isolated from the crude lysate using amylose resin (New England Biolabs) and eluted with lysis buffer supplemented with 25 mM D-(+)-maltose. The tags were removed by cleavage with HRV-3C protease.
Then, a two-fold molar excess of purified CCR4a:CAF1 heterodimer was added and the mixture incubated for two hours. Finally, the assembled complex was separated from the affinity tags and the excess of CCR4a:CAF1 by size exclusion chromatography on a Superdex 200 26/60 column (GE Healthcare) equilibrated in a buffer containing 20 mM HEPES/NaOH pH 7.5, 300 mM NaCl and 2 mM DTT. The complex was concentrated to approximately 1 mg/ml.
The residue counts and molecular weights of all recombinant complexes and their subunits are listed in Supplementary Table 3 .
